Spine BioPharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Employees
- 11
- Market Cap
- -
Moderate - Severe Degenerative Disc Disease Evaluation of the Lumbar Spine
Phase 3
Active, not recruiting
- Conditions
- Lumbar Degenerative Disc Disease
- Interventions
- Drug: SB-01 For InjectionDrug: Sham Needle
- First Posted Date
- 2022-08-26
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Spine BioPharma, Inc
- Target Recruit Count
- 400
- Registration Number
- NCT05516992
- Locations
- 🇺🇸
Pain Relief Centers, St. Petersburg, Florida, United States
🇺🇸Tampa Pain Relief Center, Tampa, Florida, United States
🇺🇸Central Alabama Research, Birmingham, Alabama, United States
© Copyright 2025. All Rights Reserved by MedPath